http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019068854-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5283edea7aac9ea8d39035f66db22f90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 |
| filingDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de062a6901053db8db07dc731c96c556 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b68709c7e5646f4cb4b55f3af9242e36 |
| publicationDate | 2019-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019068854-A |
| titleOfInvention | Screening method for substances having blood uric acid lowering action |
| abstract | PROBLEM TO BE SOLVED: To provide a screening method capable of identifying a substance capable of lowering blood uric acid level as a candidate substance without leakage and using no animal, and a pharmaceutical composition for reducing blood uric acid level. . The method includes measuring the amount of uric acid in a buffer solution after culturing liver cells in a buffer solution in the presence of a test substance, and in the case where the amount of uric acid increases due to the presence of the test substance, A method for identifying a test substance as the above candidate substance, and a pharmaceutical composition for reducing blood uric acid level, comprising a compound represented by the following formula as an active ingredient: In the formula, X represents CH 2 or COO, and R 1 to R 5 each represent H or OH. [Selected figure] Figure 5 |
| priorityDate | 2019-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 231.